@ARTICLE{
author={Smolen Josef S,Emery Paul,Rigby William,Tanaka Yoshiya,Ignacio Vargas Juan,Damjanov Nemanja S,Jain Manish,Kato K,Carter K,Khan N,Camp Heidi S,Cohen Stanley B},
year={2023},
title={Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 260 Weeks from the Select-Monotherapy Study},
journal={ANNALS OF THE RHEUMATIC DISEASES},
volume={82},
number={},
pages={723-724},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Smolen Josef S,Emery Paul,Rigby William,Tanaka Yoshiya,Vargas Juan,Damjanov Nemanja S,Jain Manish,Song Yanna,Khan Nasser,Enejosa Jeffrey,Cohen Stanley B},
year={2020},
title={Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 Weeks},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={72},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Cohen Stanley B,...,Damjanov Nemanja S,...,(broj koautora 18)},
year={2020},
title={Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, PhaseIITrial},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={72},
number={9},
pages={1435-1446},
document_type={Article},
} 

@ARTICLE{
author={Smolen Josef S,Emery Paul,Rigby William,Tanaka Yoshiya,Vargas Ignacio J,Damjanov Nemanja S,Jain Manish,Song Yanna,Khan Nasser,Enejosa Jeffrey,Cohen Stanley B},
year={2020},
title={Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 Weeks from the Select-Monotherapy Study},
journal={ANNALS OF THE RHEUMATIC DISEASES},
volume={79},
number={},
pages={327-328},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Cohen Stanley B,Tuckwell Katie,Kunder Rebecca,Katsumoto Tamiko R,Zhao Rui,Berman Alberto,Damjanov Nemanja S,Fedkov Dmytro,Jeka Slawomir,Genovese Mark C},
year={2019},
title={Efficacy and Safety of Fenebrutinib, a BTK Inhibitor, Compared to Placebo in Rheumatoid Arthritis Patients with Active Disease Despite TNF Inhibitor Treatment: Randomized, Double Blind, Phase 2 Study},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={71},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Smolen Josef S,Emery Paul,Rigby William,Tanaka Yoshiya,Ignacio Vargas Juan,Damjanov Nemanja S,Jain Manish,Sui Yunxia,Enejosa Jeffrey,Pangan Aileen L,Camp Heidi S,Cohen Stanley B},
year={2019},
title={Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis: Results at 48 Weeks},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={71},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Smolen Josef S,Emery Paul,Rigby William,Tanaka Yoshiya,Ignacio Vargas Juan,Damjanov Nemanja S,Jain Manish,Tanaka Yoshiya,Enejosa Jeffrey,Pangan Aileen L,Camp Heidi S,Cohen Stanley B},
year={2019},
title={Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis: Results at 48 Weeks from the Select-Monotherapy Study},
journal={ANNALS OF THE RHEUMATIC DISEASES},
volume={78},
number={},
pages={371-372},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Cohen Stanley B,Tuckwell Katie,Katsumoto Tamiko R,Zhao Rui,Lee Chin,Berman Alberto,Damjanov Nemanja S,Fedkov Dmytro,Jeka Slawomir,Genovese Mark C},
year={2019},
title={Fenebrutinib Compared to Placebo and Adalimumab in Patients with Inadequate Response to Either Methotrexate Therapy Or Prior Tnf Therapy: Phase 2 Study},
journal={ANNALS OF THE RHEUMATIC DISEASES},
volume={78},
number={},
pages={80-81},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Smolen Josef S,Pangan Aileen L,Emery Paul,Rigby William,Tanaka Yoshiya,Vargas Juan Ignacio,Zhang Ying,Damjanov Nemanja S,Friedman Alan,Othman Ahmed A,Camp Heidi S,Cohen Stanley B},
year={2019},
title={Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study},
journal={LANCET},
volume={393},
number={10188},
pages={2303-2311},
document_type={Article},
} 

@ARTICLE{
author={Cohen Stanley B,Cheng Tien-Tsai,Chindalore Vishala,Damjanov Nemanja S,Burgos-Vargas Ruben,DeLora Patricia,Zimany Kathleen,Travers Helen,Caulfield John P},
year={2009},
title={Evaluation of the Efficacy and Safety of Pamapimod, a p38 MAP Kinase Inhibitor, in a Double-Blind, Methotrexate-Controlled Study of Patients With Active Rheumatoid Arthritis},
journal={ARTHRITIS AND RHEUMATISM},
volume={60},
number={2},
pages={335-344},
document_type={Article},
}